Schonfeld Strategic Advisors LLC Lexicon Pharmaceuticals, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $15.4 Billion
- Q4 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 7,558,621 shares of LXRX stock, worth $5.59 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
7,558,621
Previous 1,882,600
301.5%
Holding current value
$5.59 Million
Previous $2.96 Million
89.27%
% of portfolio
0.04%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding LXRX
# of Institutions
133Shares Held
245MCall Options Held
52KPut Options Held
178K-
Artal Group S.A. Luxembourg, N4136MShares$101 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$28.8 Million1.27% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$7.32 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.88MShares$7.31 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct8.99MShares$6.65 Million0.02% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $140M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...